Inspire Medical Systems, Inc. (INSP)

NYSE: INSP · Real-Time Price · USD

76.78

+4.04 (5.55%)

At close: Sep 18, 2026, 4:00 PM EDT

78.72

+1.94 (2.53%)

After-hours: Sep 18, 2026, 7:52 PM EDT

Inspire Medical Systems Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,220	2,680	5,555	6,006	7,277	6,294
Market Cap Growth	-6.18%	-51.76%	-7.51%	-17.47%	15.63%	24.23%
Enterprise Value	1,928	2,390	5,170	5,567	6,859	6,115
Last Close Price	76.78	92.23	185.38	203.43	251.88	230.06

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.67	18.43	103.82	-	-	-
Forward PE	56.60	57.14	114.37	-	-	-
PS Ratio	2.47	2.94	6.92	9.61	17.84	26.97
PB Ratio	2.69	3.43	8.06	10.49	14.67	27.48
P/TBV Ratio	2.69	3.43	8.06	10.49	14.67	27.48
P/FCF Ratio	18.96	34.15	60.96	5865.34	2942.75	-
P/OCF Ratio	14.13	22.91	42.65	243.63	629.04	-
PEG Ratio	-	9.93	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.15	2.62	6.44	8.91	16.82	26.20
EV/EBITDA Ratio	27.03	36.82	121.26	-	-	-
EV/EBIT Ratio	35.63	46.90	143.27	-	-	-
EV/FCF Ratio	16.47	30.45	56.73	5436.59	2773.55	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.04	0.04	0.05	0.04	0.02	0.15
Debt / EBITDA Ratio	0.37	0.45	0.66	-	-	-
Debt / FCF Ratio	0.25	0.41	0.35	24.26	3.59	-
Net Debt / Equity Ratio	-0.35	-0.35	-0.60	-0.76	-0.89	-0.79
Net Debt / EBITDA Ratio	-4.09	-4.25	-9.70	11.64	9.68	4.67
Net Debt / FCF Ratio	-2.49	-3.52	-4.54	-425.32	-178.95	7.28
Asset Turnover	1.04	1.06	1.08	1.01	0.95	0.81
Inventory Turnover	0.85	1.18	2.16	4.22	4.54	2.59
Quick Ratio	5.96	4.46	6.09	7.05	8.38	6.02
Current Ratio	8.55	6.08	7.13	7.60	8.66	6.50
Return on Equity (ROE)	17.96%	19.77%	8.48%	-3.96%	-12.38%	-18.33%
Return on Assets (ROA)	3.91%	3.71%	3.04%	-4.05%	-6.92%	-8.64%
Return on Invested Capital (ROIC)	10.10%	13.05%	16.00%	-42.29%	-93.19%	-106.70%
Return on Capital Employed (ROCE)	6.30%	6.30%	5.00%	-6.70%	-9.40%	-15.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	6.08%	5.43%	0.96%	-0.35%	-0.62%	-0.67%
FCF Yield	5.27%	2.93%	1.64%	0.02%	0.03%	-0.39%
Buyback Yield / Dilution	3.84%	2.57%	-4.24%	-4.38%	-2.97%	-4.56%

SEC Filings: 10-K · 10-Q